Preview

Nephrology (Saint-Petersburg)

Advanced search

The follow-up period of children and teenagers with polycystic kidney disease

Abstract

THE AIM: To study catamnesis of children and adolescents with polycystic kidney disease (PKD). PATIENTS AND METHODS: we performed a genealogical analysis of 48 families, clinical laboratory, ultrasound (US) 98 members of 48 families in which at least one child (the proband) was observed with a diagnosis of «PKD». To determine age by the detection of cysts based on US , the features of the initial clinical manifestations and course, complications and outcome depending on the type of inheritance conducted follow-up study of 64 children and adolescents (from 48 families) with PKD aged 1 month to 18 years (mean age 13.5±4.5 years). The remoteness from the time of diagnosis of PKD by the time catamnesis in 64 children and adolescents ranged from 1 month to 17 years. RESULTS: Of the 64 children and adolescents autosomal dominant polycystic kidney disease (ADPKD) is diagnosed in 71.9%, autosomal recessive polycystic kidney disease (ARPKD) in 15.6%, unspecified polycystic kidney disease (UPKD) in 12.5% of cases. With age in patients with ADPKD there is a continuous increase of the diameter of cysts in the kidneys. The children with ARPKD revealed a progressive increase in the volume of the kidneys and the number of small cysts. The rate of detection of cysts in other organs (liver, pancreas, ovaries) in children and adolescents with ARPKD, significantly higher than that in patients with ADPKD and UPKD (70%, 6.5% and 0%, respectively). The syndrome of arterial hypertension is development in patients with ARPKD in 100% (40% at birth to 60% in infants), that it is in contrast to patients with ADPKD 32.6% of cases (moving to 100% in adults members of families with ADPKD aged 25 to 50 years). Pyelonephritis is diagnosed in children with ARPKD in 80% of cases, significantly more frequently than in children and adolescents with ADPKD (32.6%) and UPKD (37.5%). ARPKD is characterized by adverse prognosis, the outcome in chronic renal failure (90%) and deaths (30%) in the first year of life. The progression of chronic renal failure in childhood when ADPKD was significantly less (4.3%). CONCLUSION: the identified features of the initial manifestations, course and outcome of PKD in children with different types of inheritance of the disease.

About the Author

Elvira F. Andreeva
Saint-Petersburg Pediatric State Medical University
Russian Federation


References

1. Андреева ЭФ, Папаян АВ, Савенкова НД. Поликистоз почек. В: Папаян АВ, Савенкова НД. ред. Клиническая нефрология детского возраста. Левша, СПб., 2008; 121-143 [Andreeva EF, Papayan AV, Savenkova ND. Polycystic kidney disease. V: Papayan AV, Savenkova ND, red. Clinical Nephrology in childchood. Levsha, St-Peterb., 2008; 121-143]

2. Андреева ЭФ, Савенкова НД. Кистозные болезни почек у детей (обзор литературы). Нефрология 2012; (16)3: 34-47 [Andreeva EF, Savenkova ND. Cystic kidney disease in children (review). Nephrologija 2012; (16)3: 34-47]

3. The classification of renal cystic diseases and other congenital malformations of the kidney and urinary tract. Arch Pathol Lab Med 2010; 134(4): 554-568

4. Арутюнян СС, Савенкова НД. Характеристика почечных и внепочечных проявлений аутосомно-доминантного поликистоза почек у детей. Нефрология 2013; (17)3: 60-67 ^rutyunyan SS, Savenkova ND. Characteristics of renal and extrarenal manifistations of autosomal dominant polycystic kidney disease in children. Nephrologija 2013; (17)3: 60-67]

5. Арутюнян СС, Савенкова НД, Ларионова ВИ. Аутосомно-доминантный поликистоз почек у взрослых и детей (обзор литературы). Нефрология 2010; (14)3: 58-68 [Arutyunyan SS, Savenkova ND, Larionova VI. Autosomal dominant polycystic kidney disease in children and adults. Nephrologija 2010; (14)3: 58-68]

6. Huang JL, Woolf AS, Long DA. Angiogenesis and autosomal dominant polycystic kidney disease. Pediatr Nephrol 2013; 28: 1749-1755

7. Grantham JJ. Rationale for early treatment of polycystic kidney disease. Pediatr Nephrol 2015; 30: 1053-1062

8. Gansevoort RT, Arici M, Benzing T et al. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrol Dial Transplant 2016; 31: 337-348

9. Spithoven EM, Kramer A, Meijer E et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (AD-PKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant 2014; 29: 15-25

10. Riella С, Czarnecki PG, Steinman TI. Therapeutic Advances in the Treatment of Polycystic Kidney Disease. Nephron Clin Pract 2014; 128: 297-302

11. Bergmann C. ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies. Pediatr Nephrol 2015; 30: 15-30

12. Guay-Woodford LM. Autosomal recessive polycystic kidney disease: the prototype of the hepato-renal fibrocystic diseases. J Pediatr Genet 2014; 3: 89-101

13. Büscher R, Büscher AK, Weber S. Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes. Pediatr Nephrol 2014; 29:1915-1925

14. Sweeney Jr WE, Avner ED. Diagnosis and management of childhood polycystic kidney disease. Pediatr Nephrol 2011; 26: 675-692

15. Chapman AB, Devuyst O, Eckardt KU et al. Autosomaldominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2015; 88: 17-27

16. Sweeney Jr WE, Avner ED. Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy. Pediatric Research 2014; 75: 148-157

17. Liebau MC, Serra AL. Looking at the (w)hole: magnet resonance imaging in polycystic kidney disease. Pediatr Nephrol 2013; 28:1771-1783. doi: 10.1007/s00467-012-2370-y

18. Joshi SS, Paner GP, Chang SS. Polycystic Kidney Disease. In: The Kidney /edited by Hansel DE., Kane CJ., Paner GP., Chang SS. Springer. 2016; 19-35. doi: 10.1007/978-1-4939-3286-3

19. Avni FE, Hall M. Renal cystic deseases in children: new concepts. Pediatr Radiol 2010; 40: 939-946. doi: 10.1007/s00247-010-1599-5

20. Sweeney WE, Gunay-Aygun M, Patil A, Avner ED. Childhood Polycystic Kidney Disease. In: Pediatric Nephrology/ edited by Ellis Avner, William Harmon, Patrick Niaudet, Norishig Yoshikawa, Emma F, Goldstein S.L. - 7th ed. Springer. 2016; Part 6 (36): 11031153. 10.1007/978-3-662-43596-0_32

21. Dell KM. The spectrum of polycystic kidney disease in children. Adv Chronic Kidney Dis 2011; 18 (5): 339-347. doi: 10.1053/j.ackd.2011.05.001


Review

For citations:


Andreeva E.F. The follow-up period of children and teenagers with polycystic kidney disease. Nephrology (Saint-Petersburg). 2016;20(3):60-68. (In Russ.)

Views: 809


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)